Results 11 to 20 of about 20,887 (300)
Congenital or monogenic hyperinsulinism (HI) is a group of rare genetic disorders characterized by dysregulated insulin secretion and is the most common cause of persistent hypoglycemia in children.
Ethel Gonzales Clemente+3 more
doaj +2 more sources
Hyperinsulinism May Be Underreported in Hypoglycemic Patients with Phosphomannomutase 2 Deficiency
INTRODUCTION: Phosphomannomutase 2 deficiency (PMM2-CDG) is a disorder of protein N-glycosylation with a wide clinical spectrum. Hypoglycemia is rarely reported in PMM2-CDG.
Doğuş Vurallı+7 more
doaj +2 more sources
Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism
BACKGROUND The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only FDA-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI).
Preneet Cheema Brar+2 more
exaly +2 more sources
Congenital hyperinsulinism (CHI), a major cause of persistent and recurrent hypoglycemia in infancy and childhood. Numerous pathogenic genes have been associated with 14 known genetic subtypes of CHI.
Wei Zhang, Yan-Mei Sang
doaj +2 more sources
Non-coding cis-regulatory variants in HK1 cause congenital hyperinsulinism with variable disease severity [PDF]
Background We recently reported non-coding variants in a cis-regulatory element of the beta-cell disallowed gene hexokinase 1 (HK1) as a novel cause of congenital hyperinsulinism.
Jasmin J. Bennett+22 more
doaj +2 more sources
Hyperinsulinism–hyperammonemia syndrome associated with GLUD1 gene mutation: a case series [PDF]
Background Congenital hyperinsulinism is a rare disorder characterized by inappropriate insulin secretion, leading to persistent hypoglycemia. One genetic subtype, hyperinsulinism–hyperammonemia syndrome, results from activating mutations in the GLUD1 ...
Miral M. Abdulghfar+3 more
doaj +2 more sources
Risk Factors for Adverse Neurodevelopment in Transient or Persistent Congenital Hyperinsulinism
Objective Aim was to identify hypotheses why adverse neurodevelopment still occurs in children with transient or persistent hyperinsulinism despite improvements in long-term treatment options during the last decades.
Marcia Roeper+2 more
exaly +2 more sources
Hyperinsulinism and atherogenesis. [PDF]
John Yudkin, Stephen Szanto
openalex +5 more sources